fig7

Engineering a keloid-like fibrotic skin-on-a-chip for drug evaluation

Figure 7. RNA-seq analysis of the N-N-N, K-S-T, K-S-T-N, and K-S-T-F groups. (A) GO enrichment analysis of upregulated (1) and downregulated (2) genes, respectively, from the comparison between the K-S-T and K-S-T-N groups, and (3) GSEA of the “ECM organization” BP from the GO database for the same comparison; (B) GO enrichment analysis of upregulated (1) and downregulated (2) genes, respectively, from the comparison between the K-S-T and K-S-T-F groups, and (3) GSEA of the “Nuclear division” BP from the GO database for the same comparison; (C) A heatmap of TGF-β-related gene expression; (D) A heatmap of cell cycle-related gene expression; (E) A heatmap of ECM-related gene expression; (F) A heatmap of RHO/ROCK pathway- and mechanics-related gene expression; (G) Schematic illustration of fibrotic SoC model induction and pharmacological intervention. Created with BioRender.com. Data represent independent experiments performed on separate occasions using the cells from the same donor (n = 3). GO: Gene Ontology; GSEA: Gene Set Enrichment Analysis; ECM: excessive extracellular matrix; BP: biological process; TGF-β: transforming growth factor-beta; SoC: skin-on-chip; CC: cellular component; MF: molecular function; α-SMA: α-smooth muscle actin.